文献リスト

1）Conte MS. Diabetic revascularization: endovascular versus open bypass--do we have the answer? Semin Vasc Surg. 2012; 25: 108-14

2）Vogel TR, Dombrovskiy VY, Carson JL, et al. In-hospital and 30-day outcomes after tibioperoneal interventions in the US Medicare population with critical limb ischemia. J Vasc Surg. 2011; 54: 109-15

3）Sachs T, Pomposelli F, Hamdan A, et al. Trends in the national outcomes and costs for claudication and limb threatening ischemia: Angioplasty vs bypass graft. J Vasc Surg. 2011; 54: 1021-31

4）Dormandy JA, Rutherford RB. Management of peripheral arterial disease （PAD）. TASC Working Group. TransAtlantic Inter-Society Consensus （TASC）. J Vasc Surg. 2000; 31: S1-296

5） Norgren L, Hiatt WR, Dormandy JA, et al. Inter-Society Consensus for the Management of Peripheral Arterial Disease （TASC II）. J Vasc Surg. 2007; 45: S5-67

6）Marston WA, Davies SW, Armstrong B, et al. Natural history of limbs with arterial insufficiency and chronic ulceration treated without revascularization. J Vasc Surg. 2006; 44: 108-14

7）Elgzyri T, Larsson J, Thorne J, et al. Outcome of ischemic foot ulcer in diabetic patients who had no invasive vascular intervention. Eur J Vasc Endovasc Surg. 2013; 46: 110-7

8）Brass EP, Anthony R, Dormandy J, et al. Parenteral therapy with lipo-ecraprost, a lipid-based formulation of a PGE1 analog, does not alter six-month outcomes in patients with critical leg ischemia. J Vasc Surg. 2006; 43: 752-9

9）Mills JL Sr, Conte MS, Armstrong DG, et al. The Society for Vascular Surgery Lower Extremity Threatened Limb Classification System: risk stratification based on wound, ischemia, and foot infection （WIfI）. J Vasc Surg. 2014; 59: 220-34.e1-2

10）Biancari F, Salenius JP, Heikkinen M, et al. Risk-scoring method for prediction of 30-day postoperative outcome after infrainguinal surgical revascularization for critical lower-limb ischemia: a Finnvasc registry study. World J Surg. 2007; 31: 217-25; discussion 26-7

11）Schanzer A, Goodney PP, Li Y, et al. Validation of the PIII CLI risk score for the prediction of amputation-free survival in patients undergoing infrainguinal autogenous vein bypass for critical limb ischemia. J Vasc Surg. 2009; 50: 769-75

12）Schanzer A, Mega J, Meadows J, et al. Risk stratification in critical limb ischemia: derivation and validation of a model to predict amputation-free survival using multicenter surgical outcomes data. J Vasc Surg. 2008; 48: 1464-71

13）Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg （BASIL） trial: A survival prediction model to facilitate clinical decision making. J Vasc Surg. 2010; 51: 52s-68s

14）Goodney PP, Nolan BW, Schanzer A, et al. Factors associated with death 1 year after lower extremity bypass in Northern New England. J Vasc Surg. 2010; 51: 71-8

15）Arvela E, Soderstrom M, Korhonen M, et al. Finnvasc score and modified Prevent III score predict long-term outcome after infrainguinal surgical and endovascular revascularization for critical limb ischemia. J Vasc Surg. 2010; 52: 1218-25

16）Moxey PW, Brownrigg J, Kumar SS, et al. The BASIL survival prediction model in patients with peripheral arterial disease undergoing revascularization in a university hospital setting and comparison with the FINNVASC and modified PREVENT scores. J Vasc Surg. 2013; 57: 1-7

17）Iida O, Soga Y, Kawasaki D, et al. Angiographic restenosis and its clinical impact after infrapopliteal angioplasty. Eur J Vasc Endovasc Surg. 2012; 44: 425-31

18）Rastan A, Brechtel K, Krankenberg H, et al. Sirolimus-eluting stents for treatment of infrapopliteal arteries reduce clinical event rate compared to bare-metal stents: long-term results from a randomized trial. J Am Coll Cardiol. 2012; 60: 587-91

19）Liistro F, Porto I, Angioli P, et al. Drug-eluting balloon in peripheral intervention for below the knee angioplasty evaluation （DEBATE-BTK）: a randomized trial in diabetic patients with critical limb ischemia. Circulation. 2013; 128: 615-21

20）Iida O, Nakamura M, Yamauchi Y, et al. Endovascular treatment for infrainguinal vessels in patients with critical limb ischemia: OLIVE registry, a prospective, multicenter study in Japan with 12-month follow-up. Circ Cardiovasc Interv. 2013; 6: 68-76

21）Romiti M, Albers M, Brochado-Neto FC, et al. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008; 47: 975-81

22）Schanzer A, Hevelone N, Owens CD, et al. Technical factors affecting autogenous vein graft failure: Observations from a large multicenter trial. J Vasc Surg. 2007; 46: 1180-90

23）Conte MS. Technical factors in lower-extremity vein bypass surgery: how can we improve outcomes? Semin Vasc Surg. 2009; 22: 227-33

24）Singh N, Sidawy AN, Dezee KJ, et al. Factors associated with early failure of infrainguinal lower extremity arterial bypass. J Vasc Surg. 2008; 47: 556-61

25）European Stroke Organisation, Tendera M, Aboyans V, et al. ESC Committee for Practice Guidelines. ESC Guidelines on the diagnosis and treatment of peripheral artery diseases: Document covering atherosclerotic disease of extracranial carotid and vertebral, mesenteric, renal, upper and lower extremity arteries: the Task Force on the Diagnosis and Treatment of Peripheral Artery Diseases of the European Society of Cardiology （ESC）. Eur Heart J. 2011; 32: 2851-906

26）Baumann F, Fust J, Engelberger RP, et al. Early recoil after balloon angioplasty of tibial artery obstructions in patients with critical limb ischemia. J Endovasc Ther. 2014; 21: 44-51

27）Conte MS, Geraghty PJ, Bradbury AW, et al. Suggested objective performance goals and clinical trial design for evaluating catheter-based treatment of critical limb ischemia. J Vasc Surg. 2009; 50: 1462-73. e1-3

28）Scheinert D, Katsanos K, Zeller T, et al. A prospective randomized multicenter comparison of balloon angioplasty and infrapopliteal stenting with the sirolimus-eluting stent in patients with ischemic peripheral arterial disease: 1-year results from the ACHILLES trial. J Am Coll Cardiol. 2012; 60: 2290-5

29）Baumann F, Groechenig E, Diehm N. Does patency matter in patients with critical limb ischemia undergoing endovascular revascularization? Ann Vasc Dis. 2014; 7: 11-6

30）Baumann F, Engelberger RP, Willenberg T, et al. Infrapopliteal lesion morphology in patients with critical limb ischemia: implications for the development of anti-restenosis technologies. J Endovasc Ther. 2013; 20: 149-56

31）Scheller B, Hehrlein C, Bocksch W, et al. Treatment of coronary in-stent restenosis with a paclitaxel-coated balloon catheter. N Engl J Med. 2006; 355: 2113-24

32）Tepe G, Zeller T, Albrecht T, et al. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med. 2008; 358: 689-99

33）Werk M, Langner S, Reinkensmeier B, et al. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation. 2008; 118: 1358-65

34）Cassese S, Byrne RA, Ott I, et al. Paclitaxel-coated versus uncoated balloon angioplasty reduces target lesion revascularization in patients with femoropopliteal arterial disease: a meta-analysis of randomized trials. Circ Cardiovasc Interv. 2012; 5: 582-9

35）Schmidt A, Piorkowski M, Werner M, et al. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol. 2011; 58: 1105-9

36）DeRubertis BG, Pierce M, Ryer EJ, et al. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg. 2008; 47: 101-8

37） Giles KA, Pomposelli FB, Spence TL, et al. Infrapopliteal angioplasty for critical limb ischemia: relation of TransAtlantic InterSociety Consensus class to outcome in 176 limbs. J Vasc Surg. 2008; 48: 128-36

38）Bradbury AW, Adam DJ, Bell J, et al. BASIL trial Participants. Bypass versus Angioplasty in Severe Ischaemia of the Leg （BASIL） trial: An intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy. J Vasc Surg. 2010; 51: 5S-17S

39）Conrad MF, Crawford RS, Hackney LA, et al. Endovascular management of patients with critical limb ischemia. J Vasc Surg. 2011; 53: 1020-5

40）Bradbury AW, Adam DJ, Bell J, et al. Bypass versus Angioplasty in Severe Ischaemia of the Leg （BASIL） trial: Analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010; 51: 18S-31S

41）Nolan BW, De Martino RR, Stone DH, et al. Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg. 2011; 54: 730-5; discussion 5-6

42）Adam DJ, Beard JD, Cleveland T, et al. Bypass versus angioplasty in severe ischaemia of the leg （BASIL）: multicentre, randomised controlled trial. Lancet. 2005; 366: 1925-34

43）Garg K, Kaszubski PA, Moridzadeh R, et al. Endovascular-first approach is not associated with worse amputation-free survival in appropriately selected patients with critical limb ischemia. J Vasc Surg. 2014; 59: 392-9

44）Lawrence PF, Chandra A. When should open surgery be the initial option for critical limb ischaemia? Eur J Vasc Endovasc Surg. 2010; 39 Suppl 1: S32-7

NPO医学中央雑誌刊行会 https://www.jamas.or.jp/ info@jamas.or.jp